vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and DYNEX CAPITAL INC (DX). Click either name above to swap in a different company.

DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $38.9M, roughly 1.1× CODEXIS, INC.). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 81.3%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 51.0%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

CDXS vs DX — Head-to-Head

Bigger by revenue
DX
DX
1.1× larger
DX
$43.5M
$38.9M
CDXS
Growing faster (revenue YoY)
DX
DX
+450.0% gap
DX
531.3%
81.3%
CDXS
Faster 2-yr revenue CAGR
DX
DX
Annualised
DX
75.8%
51.0%
CDXS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
DX
DX
Revenue
$38.9M
$43.5M
Net Profit
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
24.7%
Revenue YoY
81.3%
531.3%
Net Profit YoY
192.5%
EPS (diluted)
$0.13
$1.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
DX
DX
Q4 25
$38.9M
$43.5M
Q3 25
$8.6M
$30.6M
Q2 25
$15.3M
$23.1M
Q1 25
$7.5M
$17.1M
Q4 24
$21.5M
Q3 24
$12.8M
Q2 24
$8.0M
Q1 24
$17.1M
$-3.2M
Net Profit
CDXS
CDXS
DX
DX
Q4 25
$9.6M
Q3 25
$-19.6M
$150.4M
Q2 25
$-13.3M
$-13.6M
Q1 25
$-20.7M
$-3.1M
Q4 24
$-10.4M
Q3 24
$-20.6M
Q2 24
$-22.8M
Q1 24
$-11.5M
$40.1M
Gross Margin
CDXS
CDXS
DX
DX
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
DX
DX
Q4 25
27.1%
Q3 25
-220.3%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
Q3 24
-129.0%
Q2 24
-284.9%
Q1 24
-69.6%
Net Margin
CDXS
CDXS
DX
DX
Q4 25
24.7%
Q3 25
-228.1%
491.3%
Q2 25
-86.6%
-58.8%
Q1 25
-274.3%
-18.0%
Q4 24
-48.4%
Q3 24
-160.8%
Q2 24
-285.2%
Q1 24
-67.4%
-1256.8%
EPS (diluted)
CDXS
CDXS
DX
DX
Q4 25
$0.13
$1.59
Q3 25
$-0.22
$1.08
Q2 25
$-0.16
$-0.14
Q1 25
$-0.25
$-0.06
Q4 24
$-0.12
Q3 24
$-0.29
Q2 24
$-0.32
Q1 24
$-0.16
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
DX
DX
Cash + ST InvestmentsLiquidity on hand
$78.2M
$531.0M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$2.5B
Total Assets
$147.8M
$17.3B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
DX
DX
Q4 25
$78.2M
$531.0M
Q3 25
$58.7M
$491.0M
Q2 25
$66.3M
$387.5M
Q1 25
$59.8M
$327.4M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
$295.7M
Total Debt
CDXS
CDXS
DX
DX
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
DX
DX
Q4 25
$50.5M
$2.5B
Q3 25
$38.5M
$2.0B
Q2 25
$55.6M
$1.6B
Q1 25
$49.6M
$1.4B
Q4 24
$66.9M
Q3 24
$73.4M
Q2 24
$61.4M
Q1 24
$79.3M
$958.5M
Total Assets
CDXS
CDXS
DX
DX
Q4 25
$147.8M
$17.3B
Q3 25
$124.0M
$14.2B
Q2 25
$138.2M
$11.3B
Q1 25
$128.9M
$9.0B
Q4 24
$149.0M
Q3 24
$148.2M
Q2 24
$132.0M
Q1 24
$149.6M
$6.3B
Debt / Equity
CDXS
CDXS
DX
DX
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
DX
DX
Operating Cash FlowLast quarter
$20.1M
$120.8M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
DX
DX
Q4 25
$20.1M
$120.8M
Q3 25
$-7.7M
$68.3M
Q2 25
$-18.0M
$31.9M
Q1 25
$-13.8M
$6.4M
Q4 24
$-16.5M
Q3 24
$-13.0M
Q2 24
$-12.2M
Q1 24
$-7.8M
$-17.1M
Free Cash Flow
CDXS
CDXS
DX
DX
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
DX
DX
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
DX
DX
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
DX
DX
Q4 25
2.09×
Q3 25
0.45×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons